UPCOMING CPD ACCREDITED WEBINAR | Wednesday 7 August, 11am (AEST)

ClearBridge Global Value Improvers Fund

This fund invests in equity securities of global companies that are considered to be undervalued, and are improving on environmental, social and governance measures through transforming their own products and services or enabling other entities to advance ESG objectives.

Key Portfolio Information

As at 28 June 2024 (returns in AUD after fees)

Performance 1 Month 3 Months 1 Year 3 Years 5 Years Inception4
ClearBridge Global Value Improvers Fund (AUD)123 -2.9% -2.1% - - - 10.1%
MSCI World Value (Net) (AUD) Index -1.3% -3.5% - - - 6.1%
Excess Returns -1.6% 1.4% - - - 4.0%

As at 30 June 2024

  • ClearBridge Global Value Improvers Fund
  • MSCI World Value Index - Net Return AUD

As at 30 June 2024

Top 10 Positions Region Sector Portfolio
Weight %
Benchmark
Weight %
Hitachi Ltd Japan Industrials 6.3% 0.0%
Totalenergies Se Europe Ex Uk Energy 4.2% 0.5%
Compass Group Plc United Kingdom Consumer Discretionary 4.0% 0.0%
Wells Fargo & Co North America Financials 3.9% 0.7%
Oracle Corp North America Information Technology 3.8% 0.7%
Banco Bilbao Vizcaya Argenta Europe Ex Uk Financials 3.7% 0.2%
Astrazeneca Plc United Kingdom Health Care 3.7% 0.0%
Meta Platforms Inc- Class A North America Communication Services 3.7% 0.0%
Fiserv Inc North America Financials 3.5% 0.3%
Nexans Sa Europe Ex Uk Industrials 3.4% 0.0%
Fund Details June 2024
APIR Code SSB5588AU
Distribution Frequency Quarterly
Lastest Distribution (CPU) 1.47
Portfolio Weighted Average June 2024
Avg Market Capitalisation 239.5bn (AUD)
PE Ratio (FY1 Est) 15.5
Price/Book 3.4
Est 3-5 Yr EPS Growth 15.3%
ROE 16.3%
Dividend Yield 2.3%

Investment Objective: To generate long term capital appreciation by investing in listed equity securities of global companies which the Portfolio Manager believes are undervalued, and are improving on certain ESG measures, either through transforming their own products and services or enabling other entities to advance ESG objectives and to outperform the benchmark, being the MSCI World Value – NR Index.

For detailed information regarding our fees and transaction costs, please refer to the relevant Product Disclosure Statement here.

Unit Prices & Distributions

Date CCY Nav Entry Exit
25/07/202425/7/24 AUD 1.1026 1.1043 1.1009
24/07/202424/7/24 AUD 1.1055 1.1072 1.1038
23/07/202423/7/24 AUD 1.1138 1.1155 1.1121
Date CCY CPU
30/06/2024 AUD 1.47

 

Product Commentary

Equity Insights Portfolio Insights
Improvers Outperform on AI Demand

Improvers Outperform on AI Demand

Q2 2024 Global Value Improvers Strategy Commentary: The Strategy outperformed its benchmark, as strong stock selection in our industrials and health care holdings overcame detractors in the financials sector.

More...
Equity Insights Portfolio Insights Video
Introducing Global Value Improvers

Introducing Global Value Improvers

Join Portfolio Manager, Grace Su as she delves into the investment philosophy supporting the ClearBridge Global Value Improvers Strategy, and explores what the Strategy aims to achieve.

More...

Investment Committee

The ClearBridge Global Value Improvers Fund is managed by an experienced investment committee comprising of the following members:

Grace Su, ClearBridge Investments, LLC
Grace Su, ClearBridge Investments, LLC
Jean Yu, CFA, PhD, ClearBridge Investments, LLC
Jean Yu, CFA, PhD, ClearBridge Investments, LLC

Important Information for Investors

Franklin Templeton Australia Limited (AFSL No. 240827) ("Franklin Templeton"), as Responsible Entity, is the issuer of the ClearBridge Global Value Improvers Fund (ARSN 673 274 201). The information contained on this website is directed to wholesale investors and financial advisers only.

Contact us to find out how we can help investors allocate global equities into their broader portfolio or to learn more about our other investment capabilities.

Contact us

Need more information?

Disclaimer

1. Sources: Internal calculations for the ClearBridge Global Value Improvers Fund. Income and growth data sourced from JPM. All index data sourced from FactSet. Results over one year annualised.
2. Fund performance is net of fees, assuming all distributions are reinvested and before tax.
3. All values in AUD and net of withholding taxes for benchmarks, if applicable. Non-AUD values converted into AUD using FactSet Forex data.
4. Performance inception date for the ClearBridge Global Value Improvers Fund is 18/01/2024.

Past performance is not indicative of future performance. 

While the information contained on this website has been prepared with all reasonable care, ClearBridge Investments* accepts no responsibility or liability for any errors, omissions or misstatements however caused. Any views expressed on this website are given as of the date of publication and such views are subject to change at any time.

This information is not personal advice. It has been prepared without taking account of individual objectives, financial situation or needs. Where an investment product is mentioned, potential investors should seek independent advice as to the suitability of the product to their investment needs. Reference to shares in a particular company, is not a recommendation to buy, sell or hold that stock. Investors should be aware that past performance is not indicative of future performance.

This website may contain forecasts, including in regard to targets, expected returns, PE ratios and dividend yields. Any such statements are based upon research undertaken by the investment teams. This research incorporates our reasonable assumptions and beliefs concerning future developments and their potential effect but are subject to risks and uncertainties that may be beyond our control. Returns can be volatile, reflecting rises and falls in the value of underlying investments. Accordingly, we do not provide any assurance or guarantee that future developments will be aligned with our expectations, and actual results may differ materially from those expected or anticipated at the time of writing.

Franklin Templeton Australia Limited (AFSL No. 240827) (“Franklin Templeton”) is a part of Franklin Resources, Inc. and the Responsible Entity for certain ClearBridge managed Funds (the “Funds”). Applications to invest can only be made on the application form accompanying the most recent Fund Product Disclosure Statement (“PDS”) which is available on this website.

Potential investors should read the relevant PDSs and the Additional Information Booklet (“AIB”) before making an investment decision. The PDSs and AIB can be obtained on this website or by contacting us: by telephone on (02) 9397 7351, by writing to ClearBridge Investments Limited (ABN 84 119 339 052; AFSL No. 307727), Level 13, 35 Clarence Street, Sydney, NSW 2000 or by email at [email protected]. Franklin Templeton can be contacted by writing to Franklin Templeton, Level 47, 120 Collins Street, Melbourne, VIC 3000 or by telephone on 1800 673 776. 

In accordance with the Design and Distribution Obligations and Product Interventions Powers requirements the Responsible Entity maintains Target Market Determinations (“TMD”) for each of the Funds. All documents can be found on this website on the Forms & Downloads page, by contacting Client Service on (02) 9397 7351 or by email at [email protected].

Franklin Templeton does not guarantee any rate of return or the return of capital invested. Investments are subject to risks, including, but not limited to, possible delays in payments and loss of income or capital invested.

ClearBridge Investments is wholly, indirectly owned by Franklin Resources, Inc.

*ClearBridge Investments consists of ClearBridge Investments, LLC. (“CBI”) and its affiliated managers whose businesses have been operationally integrated with CBI’s, including ClearBridge Investments Limited and its subsidiary in Australia, and a part of Franklin Templeton Investments Corp. doing business as ClearBridge Investments in Canada.